Delivery Order SPE2DB25D3012-SPE2DB25FWYPX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) on September 3, 2025, with completion scheduled for September 24, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) on August 19, 2025, with completion targeted for September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $21,282.14 delivery order to AmerisourceBergen Drug Corp for TAGRISSO 40 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, firm fixed-price contract represents a delivery order under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $31,892.74 delivery order to AmerisourceBergen Drug Corp for TAGRISSO (80 mg tablets, 30-count package) under a firm fixed-price contract type. The award was issued on September 17, 2025, with an ultimate completion date of October 8, 2025, and represents a competitively awarded non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, leveraging its established...
- The Defense Logistics Agency awarded a $10,662.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count) on August 11, 2025, with completion scheduled for September 2, 2025. This non-set-aside award represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,236.71 to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count supply) on November 20, 2025, with completion targeted for December 12, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order under...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 mg tablets (30-count packaging) on July 29, 2025, with an ultimate completion date of August 19, 2025. The contract employs firm fixed-price pricing and was not issued under any set-aside designation, indicating competitive award through open competition. Performance of this delivery order is based at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $21,325.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count packaging), with an ultimate completion date of November 17, 2025. This non-set-aside contract represents a competitive award for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 20, 2025, for the supply of TAGRISSO 80 mg tablets (30-count units) with a contract value of $10,662.57. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 11, 2025, and performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a $10,662.57 delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) under a firm fixed price contract. The delivery order, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWYPXDelivery Order
The Defense Logistics Agency awarded a $10,662.57 delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count packages) on July 14, 2025, with a completion date of August 4, 2025. This contract represents a firm fixed-price, non-set-aside award executed under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems across multiple therapeutic domains. This delivery order falls within AmerisourceBergen Drug Corp's comprehensive pharmaceutical supply vehicle with the Defense Logistics Agency, which enables the company to fulfill medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The award demonstrates the contractor's capability to meet federal procurement requirements through competitive processes, as evidenced by its consistent receipt of non-set-aside delivery orders ranging from minimal to substantial values. The DLA's Pharmaceutical Prime Vendor Global Program strategy, which plans multiple awards across separate regions, positions AmerisourceBergen Drug Corp as one of several strategic contractors supporting the Department of Defense's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 7/14/25 |